Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Population Pharmacokinetic/Pharmacodynamic Analysis of Alirocumab in Healthy Volunteers or Hypercholesterolemic Subjects Using an Indirect Response Model to Predict Low-Density Lipoprotein Cholesterol Lowering: Support for a Biologics License Application Submission: Part II.
Nicolas X, Djebli N, Rauch C, Brunet A, Hurbin F, Martinez JM, Fabre D. Nicolas X, et al. Clin Pharmacokinet. 2019 Jan;58(1):115-130. doi: 10.1007/s40262-018-0670-5. Clin Pharmacokinet. 2019. PMID: 29725997 Free PMC article. Clinical Trial.
Safety, pharmacokinetics, and target engagement of a brain penetrant RIPK1 inhibitor, SAR443820 (DNL788), in healthy adult participants.
Hincelin-Mery A, Nicolas X, Cantalloube C, Pomponio R, Lewanczyk P, Benamor M, Ofengeim D, Krupka E, Hsiao-Nakamoto J, Eastenson A, Atassi N. Hincelin-Mery A, et al. Among authors: nicolas x. Clin Transl Sci. 2024 Jan;17(1):e13690. doi: 10.1111/cts.13690. Epub 2023 Dec 11. Clin Transl Sci. 2024. PMID: 38010108 Free PMC article. Clinical Trial.
Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2).
Tamura K, Mukohara T, Yonemori K, Kawabata Y, Nicolas X, Tanaka T, Iwata H. Tamura K, et al. Among authors: nicolas x. Breast Cancer. 2023 May;30(3):506-517. doi: 10.1007/s12282-023-01443-8. Epub 2023 Mar 29. Breast Cancer. 2023. PMID: 36977973 Free PMC article. Clinical Trial.
[Extensive bone marrow necrosis and sickle cell disease].
Pougnet L, Dagorne A, Sapin-Lory J, Boutefeu F, Nicolas X, Le Guen P, Drouillard I, Désidéri-Vaillant C. Pougnet L, et al. Among authors: nicolas x. Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):590-2. doi: 10.1684/abc.2013.0890. Ann Biol Clin (Paris). 2013. PMID: 24113446 Free article. French.
[A melanesian smile…].
Désidéri-Vaillant C, Di Costanzo L, Di Filipo J, Sapin-Lory J, Le Louarn S, Nicolas X. Désidéri-Vaillant C, et al. Among authors: nicolas x. Ann Biol Clin (Paris). 2013 Sep-Oct;71(5):585-6. doi: 10.1684/abc.2013.0886. Ann Biol Clin (Paris). 2013. PMID: 24113444 Free article. French.
[Campylobacter fetus endocarditis: a case report].
Désidéri-Vaillant C, Guichon JM, Noyer V, Nedelec Y, Galinat H, Sapin-Lory J, Di Costanzo L, Le Guen P, Nicolas X. Désidéri-Vaillant C, et al. Among authors: nicolas x. Ann Biol Clin (Paris). 2013 Jul-Aug;71(4):465-7. doi: 10.1684/abc.2013.0862. Ann Biol Clin (Paris). 2013. PMID: 23906576 Free article. French.
68 results